• news

• Corona

Negotiations with Pfizer and the implications for the epidemic: Experts explain the drug to Corona

Bennett and Ash announced that the purchase of the drug "Paxlobid" was under discussion, and instilled optimism in the ongoing fight against the epidemic.

When is it expected to arrive in Israel, how is it different from other drugs, for whom is it intended and in what dosage - and is Israel really lagging behind the other countries?

Tags

• Corona virus

• Pfizer

Meirav Cohen

Monday, 08 November 2021, 00:01

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments

In the video: Pfizer CEO refers to Corona's new drug (Photo: Reuters)

Prime Minister Naftali Bennett and Health Ministry Director General Prof. Nachman Ash announced today (Sunday) that the government is preparing to purchase the drug for Pfizer's coronary virus. to Israel.

why is it different from previous treatments epidemic, how effective it is, who gets it and what dose, and whether Israel really lag against other countries in the negotiations with the drug company?

The experts answer the questions.

More on Walla!

Director General of the Ministry of Health: Agreement to purchase Pfizer's Corona drug - in the coming days

To the full article

Optimism from the drug (Photo: Reuters)

What is the difference between it and other antiviral drugs that are in the experimental stages?

Dr. Erez Gerty of the Davidson Institute, the educational arm of the Weizmann Institute, explains that “if the results are correct, there is a significant change here in the way we deal with the corona.

According to Pfizer data, there is between 85-89% hospitalization prevention and mortality.

In the experiment, we saw a difference in the data between the control group and the experimental group, when in the control group that received a placebo, ten patients died and 40 came to the hospital.

In the experiment only six came to the hospital and no one died.

"That is the difference is the good quality of the drug and the fact that it can be obtained in the community and it is not given through a vein, but through a pill, so there is no need for medical intervention."

Who is it for?

Tal Brosh, head of infectious disease at Assuta Ashdod and secretary of the IDF committee, explains that the drug is intended for those who have begun to develop symptoms of the disease.

We have not yet decided whether a family doctor will be able to give the drug or just an infectious disease specialist, but the goal is that it will be easily given in the community.

" The disease is severe due to the vaccine, "he added. The drug currently used in Israel is also given without vaccines because they are less protected.

A turning point in treating an epidemic?

Corona Department in Sheba (Photo: Reuters)

Will it change the face of the plague as we know it?

In the words of Dr. Brosh, “We have been looking for a long time for a way to treat Corona.

Once we have a patient with severe corona we do not have many solutions, it is clear that we need to intervene early - right in the first few days.

What has been tested so far has not succeeded.

The drug is not a vaccine substitute but a second line of vaccine.

Slowly we get to the point where we will have end-to-end treatment - from preventing the disease and epidemic with the help of the vaccine, including a special vaccine in the future for people with immunosuppression, and then if they get infected they will get one of the drugs we offer.

The drug will not lower the infection - for this there is the vaccine.

The drug provides us with the completion of treatment in case the person is already infected.

There is no doubt that this is a real line. "

Is the State of Israel lagging behind the world in purchasing the drug?

Prof. Nadav Davidovich, acting chairman of the Public Health Association, said that "negotiations are underway between the Ministry of Health and Pfizer. Israel has warm ties with Pfizer and we will not have a purchase problem once the drug is approved. The Ministry of Health knows the experiment The drug is expected to be negotiated for purchase. "The drug is expected to be approved by the US Food and Drug Administration (FDA) by the end of the month, and will probably arrive in Israel shortly thereafter.

Davidovich cools the enthusiasm: It's good that we have another tool to help us face it.

It is important to remember that still the most important thing is prevention - vaccination, hygiene, classroom ventilation.

It is as true for Corona as for any disease, it is better to be vaccinated than a drug. "

• Share on Facebook

• Share on WhatsApp

• Share on general

• Share on general

• Share on Twitter

• Share on Email

0 comments